Literature DB >> 11216561

Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics.

R J Elwell1, G R Bailie, H J Manley.   

Abstract

OBJECTIVE: To identify correlations between the pharmacokinetic variables that describe drug disposition in peritoneal dialysis (PD) patients and the measures used to assess dialysis adequacy. DESIGN AND METHODS: This retrospective study re-evaluated data collected during previous pharmacokinetic studies for intraperitoneally administered cefazolin, ceftazidime, and gentamicin in continuous ambulatory peritoneal dialysis (CAPD) patients, and intravenous cefazolin and tobramycin in automated PD patients. Pharmacokinetic variables were compared to creatinine clearance (CCr), Kt/V, and peritoneal equilibration test data using the Pearson product correlation coefficient (r).
RESULTS: Prominent correlations were found between renal CCr and renal Kt/V, with renal clearances of CAPD cefazolin and ceftazidime, and automated PD tobramycin and cefazolin (r values ranged from 0.698 to 0.986; p < 0.05).
CONCLUSION: These findings support current peritonitis treatment recommendations that patients with residual renal function may require higher doses or more frequent drug administration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11216561

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  4 in total

1.  Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).

Authors:  Julie M Varghese; Jason A Roberts; Steven C Wallis; Robert J Boots; Helen Healy; Robert G Fassett; Jeffrey Lipman; Dwarakanathan Ranganathan
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-14       Impact factor: 8.237

2.  Pharmacokinetic profiles of ceftazidime after intravenous administration in patients undergoing automated peritoneal dialysis.

Authors:  Kiwon Kim; Young-Hwan Hwang; Han Ro; Yun Kyu Oh; Min-Gul Kim; Kyung-Sang Yu; Kwang-Hee Shin; In-Jin Jang; Sang Goo Shin; Curie Ahn; Kook-Hwan Oh
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

3.  Residual Kidney Function and Peritoneal Dialysis-Associated Peritonitis Treatment Outcomes.

Authors:  Rachel Whitty; Joanne M Bargman; Alex Kiss; Linda Dresser; Philip Lui
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-07       Impact factor: 8.237

4.  Medication dosing and renal insufficiency in a pediatric cardiac intensive care unit: impact of pharmacist consultation.

Authors:  Brady S Moffett; Antonio R Mott; David P Nelson; Karen D Gurwitch
Journal:  Pediatr Cardiol       Date:  2007-12-14       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.